SlideShare a Scribd company logo
1 of 20
Seminar on
DIURETICS
Submittedby
Samarjit Bose
Roll No:17401913041
Reg.No:13174021042
S_ID:B1309
B.Pharm, 3rd Year,6th Semester
Netaji Subhas Chandra Bose Institute of
Pharmacy
Tatla, Roypara, Chakdaha, Dist-Nadia, Pin- 741222
Affiliated to
Maulana Abul Kalam Azad University of
Technology
BF-142, Sector 1, Saltlake City, Kolkata-700064,West
Bengal.
ACKNOWLEDGEMENT
This seminar report entitled “DIURETICS” is by far the most significant
scientific accomplishment in my life and I was inspired to work in front
of my supervisor Principal Dr. Arnab Samanta. I take this opportunity to
humble acknowledge the contribution my supervisor, her philosophy to
venture into unknown field sciences opened up new avenues and horizons
before me while pursuing the investigation. Without her constant
encouragement, motivation, fruitful suggestions and inspiration my
review work would not have been materialized.
Next I thank and express my sincere gratitude to the Principal Dr. Arnab
Samanta and I wish to pay my humble respect to all of my teachers who
have nurtured and developed the loyal spirit of education in me for the
facilities has provided.
I am also expressing the thanks to review papers which I consulted during
my review work, I have acknowledged them in reference section of this
report.
Last but not the least; I dedicate the pleasure of presenting this report at
the lotus feet of the Almighty.
Samarjit Bose
(6th Semester, 3rd Year)
NETAJI SUBHAS CHANDRA BOSE
INSTITUTE OF PHARMACY
TATLA, ROYPARA, CHAKDAHA, NADIA, PIN 741222.
Estd. 2004
CERTIFICATE
This is to certify that the report entitled, “DIURETICS” submitted
by Mr. SAMARJIT BOSE, 3rdYear, 6thSemester under guidance
of Dr. Arnab Samanta in partial fulfilment for the award of degree
of B.Pharm under MAKAUT.
Dr. Arnab Samanta
Principal of NSCBIP
4
CONTENT PAGE NO
A. Definition………………………………....4
B. Pharmacological classification………….5
C. Loop diuretics…………………………... 7- 9
D. Thiazides……………………………….10-11
E. Carbonic anhydrase inhibitor………...12-13
F. Potassium sparing diuretics……………14-15
1. Aldosterone antagonists
2. Epithelial sodium channel blockers
G. Osmotic diuretics…….………………16-17
H. Reference…………………………………18
5
DEFINITION :-
Diuretics are chemicals that increase the rate of urine formation. By
increasing the urine flow rate, diuretic usage leads to the increased
excretion of electrolytes (especially sodium and chloride ion) and
water from the body.
Diuretics are the drugs which cause a net loss of sodium ion and
water in urine. These drugs increase urine output by the kidney
(promote diuresis). This is accomplishedbyalteringhow the kidney
handles sodium. If the kidney excretes more sodium, then water
excretion will also increase. Most diuretics produce diuresis by
inhibiting the reabsorption of sodium at different segments of the
renal tubular system. Sometimes a combination of two diuretics is
given because this can be significantly more effective than either
compound alone (synergisticeffect).
 Example of diuretics are caffeine, yerba mate, nettles, cranberry
juice, alcohol
• Natriuretic: substance that promotes the renal excretion of Na+
6
PHARMACOLOGICAL CLASSIFICATION
1. Loop diuretics
2. Thiazides
3. Carbonic anhydrase inhibitor
4. Potassium sparing diuretics
1. Aldosterone antagonists
2. Epithelial sodium channel
blockers
5. Osmotic diuretics
7
SUMMARY: SITES OF ACTION
V
8
Loop diuretics (Inhibitors of Na+K+2Cl -cotransport):-
High ceiling diuretics are diuretics that may cause a substantial
diuresis up to 20% of the filtered load of NaCl and water. This is
huge when compared to normal renal sodium reabsorption which
leaves only ~0.4% of filtered sodium in the urine. High ceiling
diuretics often synonymous with Loop diuretics.
 Mechanism of action:
 Loop diuretics inhibit the body's ability to reabsorb sodium at the
ascending loop in the kidney which leads to a retention of water in
the urine.
 No transport systems in descending loop of henle.
 Inhibits Na-K-2Cl transporter in thick ascending loopof henle.
 Competes with Cl- binding site.
 Use : a. edema: cardiacpulmonaryor renal,
b. hypertension
 Example of loop diuretics include Furosemide, Bumetanide,
Ethacrynicacid and Torsemide
 Use : a. edema: cardiacpulmonaryor renal,
b. hypertension
 Example of loop diuretics include Furosemide, Bumetanide,
Ethacrynicacid and Torsemide
9
A .Furosemide-
• The major site of action is the thick AscLH where furosemide
inhibits Na+-K+-2Cl-cotransport. A minor componentofaction on
PT has also been indicated. It is secreted in PT by organic action
transport and reaches Asc LH where it acts from luminal side of
the membrane. . K+ excretion is increased mainly due to high Na+
load reaching DT.
• Furosemide has weak Case inhibitory action,
• increase HCO3 excretion.
B. Bumetanide-
• Bumetanide is similar to furosemide in all respect, but is 40 times
more potent. A secondary action in PT has alsobeen demonstrated.
• It is often used in people in whom high dosage of
furosemide are ineffective.
• It is more lipid –soluble ,oral bioavailabilityis
80%-100%.itis preferred for oral use in severe CHF.
C. Ethacrynicacid-
• It is a loop diuretics used totreathigh blood pressure and swelling
caused by diseases like CHF.
10
D. Torsemide-
• Another loop diureticwith properties similar to
furosemide but 3 times more potent.
11
Thiazides :-
Thiazide is a type of molecule and a class
of diuretics often used to treat hypertension (high blood
pressure) and edema (such as that caused by heart, liver,
or kidney disease).
The thiazides and thiazide-like diuretics reduce the risk
of death, stroke, heart attack, and heart failure due to
hypertension
Mechanism of action :
active in distal convoluted tubule
inhibit Na+ and Cl- transporter in
distal convoluted tubules
increased Na+ and Cl- excretion
weak inhibitors of carbonic anhydrase,
increased HCO3- excretion
Use : a. hypertension.
b. congestive heart failure.
c. high blood pressure.
Example of thiazides include Chlorthalidone,
Hydroclorothiazide, Metolazone
12
1. Hydrochlorothiazide - Hydrochlorothiazide
belongs to thiazide class of diuretics. It reduces
blood volume by acting on the kidneys to
reduce sodium (Na+) reabsorption in the distal
convoluted tubule.
2. Chlorothalidone - It is a particularly long bacting
compound .use exclusively asm antihypertensive.
3. Metolazone - Inhibit PO4 reabsorption is occur in
PT. Metolazone has been used mainly for edema
(5-10 mg/day, rarely 20 mg).
DRUG DAILY DOSE
(mg)
DURATION OF
ACTION
(hr)
Hydroclorothiazide 12.5-100 6-12
Chlorothalidone 50-100 48
Metolazone 5- 20 12-24
13
4.Carbonic anhydrase inhibitor :-
High concentration of CA occur in ciliary process of
eye. CA enzyme involve in aqueous humor
formation.CA inhibitors reduce intraocular pressure
in glaucoma by decreasing production of aqueous
humor.
 Mechanismof action :
 Reversibly inhibits carbonic anhydrase in renal
proximal tubule cells.
 carbonic anhydrase catalyzes formation of HCO3- and
H+
from H2O and CO2.
 Suppress CO2 reabsorption from glomerular filtrate.
 Na+ - HCO3
- excretion is increased.
Use : a. used to treat chronic open-angle
glaucoma
b. aqueous humor has high [HCO3-]
c. acute mountain sickness.
 Example of carbonic anhydrase inhibitor
include Acetazolamide.
14
1. Acetazolamide –
• Acetazolamide (a seet" a zol' a mide) is inhibitorSE4 of carbonic
anhydrase, an enzyme that converts carbon dioxide and water to
carbonic acid. Inhibition of this enzyme in the kidney causes an
alkalization of the urine and diuresis. In the eye, inhibition of
carbonic anhydrase causes a decrease in intraocular pressure
making these agents valuable in the treatmentof glaucoma.
• Acetazolamide is available in 125 and 250 mg tablets in generic
forms and under the brand name of Diamox.
15
Potassium sparing diuretics :-
Aldosterone antagonists and renal epithelial Na+
channel inhibitors indirectly conserve k+ while inducing
mild natriuresis, and are called potassium sparing
diuretics.
Mechanismof action :
K+ sparing diuretics function in CCD
Do not promote the secretion of potassium into the
urine.
decrease Na+ transport in collecting tubule.
 Aldosterone antagonist- These medicines
block the action of a hormone called aldosterone and
this causes the kidney to pass out more fluid and keep
potassium. This is why they are sometimes referred
to as aldosterone antagonists. Example of this
antagonist include Spironolactone.
 Inhibitor of renal epithelial Na+ channel-
Triamterene and amiloride are two nonsteroidal
organic base with identical action. their most
important effect is to decrease K+ excretion,
particularly when it is high due to large K+ intake
or use of a diuretic that enhances K+ loss. This is
accompanied by a small increase of Na+ excretion.
16
Use : a. primary hyperaldosteronism
b. cirrhosis
Example of potassium sparing diuretics include
Spironolactone , Triamterene, Amiloride.
17
.
Osmotic diuretics :-
Osmotic diuresis is the increase of urination rate caused
by the presence of certain substances in the small tubes of
the kidneys.[2] The excretion occurs when substances
such as glucose enter the kidney tubules and cannot be
reabsorbed (due to a pathological state or the normal
nature of the substance). The substances cause an
increase in theosmotic pressure within the tubule,
causing retention of water within the lumen, and thus
reduces the reabsorption of water, increasing urine
output (i.e. diuresis).
Mechanismof action :
 osmotic diuretics are not reabsorbed.
 increases osmotic pressure specifically in the
proximal tubule and loop of Henle.
 prevents passive reabsorption of H2O.
 increased Na+ excretion.
Use : a. drug of choice: non-toxic, freely filtered,
non-absorbable
b. administered prophylactically for CVS
disease, surgery.
c. for acute renal failure secondary to trauma.
18
Example of osmotic diuretics include Manitol,
Urea, Glycerol
Manitol –
Manitol is a nonelectrolyte of low molecular
weight (182) that is pharmacologically inert ,can be
rise osmolarity of plasma and tubular fluid. It is
minimally metabolized in the body ,freely filtered at
the glomerulus and undergoes limited reabsorbtion.
19
REFERENCE:-
A. KD TRIPATHI MD (Ex-Director-Professor and Head of
Pharmacology Maulana Azad Medical College and associated LN
and GB Pant Hospitals New Delhi), Essentials of Medical
Pharmacology, 5th Edition, 2003: 521-537.
B. http://en.wikipedia.org/wiki/Diuretic.
C.http://www.medpagetoday.com/MeetingCoverage/ HFC/ 32821

More Related Content

What's hot

Diuretics by srota dawn
Diuretics by srota dawnDiuretics by srota dawn
Diuretics by srota dawn
Srota Dawn
 

What's hot (20)

Diuretics
Diuretics Diuretics
Diuretics
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics (shoriful)
Diuretics (shoriful)Diuretics (shoriful)
Diuretics (shoriful)
 
2nd unit diuretics
2nd unit diuretics2nd unit diuretics
2nd unit diuretics
 
Diuretics pharmacology
Diuretics pharmacologyDiuretics pharmacology
Diuretics pharmacology
 
Diuretics
DiureticsDiuretics
Diuretics
 
6 diuretic
6 diuretic6 diuretic
6 diuretic
 
Diuretics
DiureticsDiuretics
Diuretics
 
5diuretics class
5diuretics class5diuretics class
5diuretics class
 
Diuretics new
Diuretics newDiuretics new
Diuretics new
 
Diuretic_Diksha
Diuretic_DikshaDiuretic_Diksha
Diuretic_Diksha
 
Diuretics...
Diuretics...Diuretics...
Diuretics...
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics & Their Mechanism.PPT
Diuretics & Their Mechanism.PPTDiuretics & Their Mechanism.PPT
Diuretics & Their Mechanism.PPT
 
Diuretics by srota dawn
Diuretics by srota dawnDiuretics by srota dawn
Diuretics by srota dawn
 
Thiazide diuretics
Thiazide diureticsThiazide diuretics
Thiazide diuretics
 
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
 
Diureticsvpp
DiureticsvppDiureticsvpp
Diureticsvpp
 
Diuretics
DiureticsDiuretics
Diuretics
 

Viewers also liked (11)

Diuretics
DiureticsDiuretics
Diuretics
 
Tablets
TabletsTablets
Tablets
 
DIURETICS PNA---PDF
DIURETICS PNA---PDFDIURETICS PNA---PDF
DIURETICS PNA---PDF
 
Class diuretics
Class diureticsClass diuretics
Class diuretics
 
Diuretics by P.Ravisankar
Diuretics by P.RavisankarDiuretics by P.Ravisankar
Diuretics by P.Ravisankar
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics2
Diuretics2Diuretics2
Diuretics2
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretic drugs
Diuretic drugsDiuretic drugs
Diuretic drugs
 
Quiz on pharmacology
Quiz on pharmacologyQuiz on pharmacology
Quiz on pharmacology
 

Similar to Word copy diuretics

Diuretics : Dr Renuka Joshi MD,DNB, (FNB )
Diuretics : Dr Renuka Joshi MD,DNB, (FNB )Diuretics : Dr Renuka Joshi MD,DNB, (FNB )
Diuretics : Dr Renuka Joshi MD,DNB, (FNB )
Renuka Buche
 
Lecture №6-1.pptx..Asian Medical Institute
Lecture №6-1.pptx..Asian Medical InstituteLecture №6-1.pptx..Asian Medical Institute
Lecture №6-1.pptx..Asian Medical Institute
VijitaPriya
 

Similar to Word copy diuretics (20)

Souvik diueretics note ppt
Souvik diueretics note pptSouvik diueretics note ppt
Souvik diueretics note ppt
 
3.Diuretics
3.Diuretics3.Diuretics
3.Diuretics
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics ppt for BAMS students
Diuretics  ppt for BAMS students Diuretics  ppt for BAMS students
Diuretics ppt for BAMS students
 
Renal pharmacology
Renal pharmacologyRenal pharmacology
Renal pharmacology
 
Diuretics and antidiuretics detail STUDY
Diuretics and antidiuretics detail STUDYDiuretics and antidiuretics detail STUDY
Diuretics and antidiuretics detail STUDY
 
Diuretics : Dr Renuka Joshi MD,DNB, (FNB )
Diuretics : Dr Renuka Joshi MD,DNB, (FNB )Diuretics : Dr Renuka Joshi MD,DNB, (FNB )
Diuretics : Dr Renuka Joshi MD,DNB, (FNB )
 
Diuretics
DiureticsDiuretics
Diuretics
 
Diuretics
DiureticsDiuretics
Diuretics
 
diuretics.pptx
diuretics.pptxdiuretics.pptx
diuretics.pptx
 
Lecture 1 adithan diuretics july 22, 2016 mgmcri
Lecture 1 adithan diuretics july 22, 2016 mgmcriLecture 1 adithan diuretics july 22, 2016 mgmcri
Lecture 1 adithan diuretics july 22, 2016 mgmcri
 
Lecture №6-1.pptx..Asian Medical Institute
Lecture №6-1.pptx..Asian Medical InstituteLecture №6-1.pptx..Asian Medical Institute
Lecture №6-1.pptx..Asian Medical Institute
 
Diuretics presentation by DVM student Hamza Jawad
Diuretics presentation by DVM student Hamza JawadDiuretics presentation by DVM student Hamza Jawad
Diuretics presentation by DVM student Hamza Jawad
 
A presentation on DIURETICS and their potential
A presentation on DIURETICS and their potentialA presentation on DIURETICS and their potential
A presentation on DIURETICS and their potential
 
Pharmacology of diuretics-antidiuretics
Pharmacology of diuretics-antidiureticsPharmacology of diuretics-antidiuretics
Pharmacology of diuretics-antidiuretics
 
Diuretics-Antiemetics-ADRs-MM-pharm-weekend-15.03-Alex-Conway.pptx
Diuretics-Antiemetics-ADRs-MM-pharm-weekend-15.03-Alex-Conway.pptxDiuretics-Antiemetics-ADRs-MM-pharm-weekend-15.03-Alex-Conway.pptx
Diuretics-Antiemetics-ADRs-MM-pharm-weekend-15.03-Alex-Conway.pptx
 
793264.ppt
793264.ppt793264.ppt
793264.ppt
 
Diuretic
Diuretic Diuretic
Diuretic
 
Diuretics
DiureticsDiuretics
Diuretics
 
CHAPTER 1.pptx
CHAPTER 1.pptxCHAPTER 1.pptx
CHAPTER 1.pptx
 

Recently uploaded

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 

Recently uploaded (20)

Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 

Word copy diuretics

  • 1. Seminar on DIURETICS Submittedby Samarjit Bose Roll No:17401913041 Reg.No:13174021042 S_ID:B1309 B.Pharm, 3rd Year,6th Semester Netaji Subhas Chandra Bose Institute of Pharmacy Tatla, Roypara, Chakdaha, Dist-Nadia, Pin- 741222 Affiliated to
  • 2. Maulana Abul Kalam Azad University of Technology BF-142, Sector 1, Saltlake City, Kolkata-700064,West Bengal. ACKNOWLEDGEMENT This seminar report entitled “DIURETICS” is by far the most significant scientific accomplishment in my life and I was inspired to work in front of my supervisor Principal Dr. Arnab Samanta. I take this opportunity to humble acknowledge the contribution my supervisor, her philosophy to venture into unknown field sciences opened up new avenues and horizons before me while pursuing the investigation. Without her constant encouragement, motivation, fruitful suggestions and inspiration my review work would not have been materialized. Next I thank and express my sincere gratitude to the Principal Dr. Arnab Samanta and I wish to pay my humble respect to all of my teachers who have nurtured and developed the loyal spirit of education in me for the facilities has provided. I am also expressing the thanks to review papers which I consulted during my review work, I have acknowledged them in reference section of this report. Last but not the least; I dedicate the pleasure of presenting this report at the lotus feet of the Almighty. Samarjit Bose (6th Semester, 3rd Year)
  • 3. NETAJI SUBHAS CHANDRA BOSE INSTITUTE OF PHARMACY TATLA, ROYPARA, CHAKDAHA, NADIA, PIN 741222. Estd. 2004 CERTIFICATE This is to certify that the report entitled, “DIURETICS” submitted by Mr. SAMARJIT BOSE, 3rdYear, 6thSemester under guidance of Dr. Arnab Samanta in partial fulfilment for the award of degree of B.Pharm under MAKAUT. Dr. Arnab Samanta Principal of NSCBIP
  • 4.
  • 5. 4 CONTENT PAGE NO A. Definition………………………………....4 B. Pharmacological classification………….5 C. Loop diuretics…………………………... 7- 9 D. Thiazides……………………………….10-11 E. Carbonic anhydrase inhibitor………...12-13 F. Potassium sparing diuretics……………14-15 1. Aldosterone antagonists 2. Epithelial sodium channel blockers G. Osmotic diuretics…….………………16-17 H. Reference…………………………………18
  • 6. 5 DEFINITION :- Diuretics are chemicals that increase the rate of urine formation. By increasing the urine flow rate, diuretic usage leads to the increased excretion of electrolytes (especially sodium and chloride ion) and water from the body. Diuretics are the drugs which cause a net loss of sodium ion and water in urine. These drugs increase urine output by the kidney (promote diuresis). This is accomplishedbyalteringhow the kidney handles sodium. If the kidney excretes more sodium, then water excretion will also increase. Most diuretics produce diuresis by inhibiting the reabsorption of sodium at different segments of the renal tubular system. Sometimes a combination of two diuretics is given because this can be significantly more effective than either compound alone (synergisticeffect).  Example of diuretics are caffeine, yerba mate, nettles, cranberry juice, alcohol • Natriuretic: substance that promotes the renal excretion of Na+
  • 7. 6 PHARMACOLOGICAL CLASSIFICATION 1. Loop diuretics 2. Thiazides 3. Carbonic anhydrase inhibitor 4. Potassium sparing diuretics 1. Aldosterone antagonists 2. Epithelial sodium channel blockers 5. Osmotic diuretics
  • 9. 8 Loop diuretics (Inhibitors of Na+K+2Cl -cotransport):- High ceiling diuretics are diuretics that may cause a substantial diuresis up to 20% of the filtered load of NaCl and water. This is huge when compared to normal renal sodium reabsorption which leaves only ~0.4% of filtered sodium in the urine. High ceiling diuretics often synonymous with Loop diuretics.  Mechanism of action:  Loop diuretics inhibit the body's ability to reabsorb sodium at the ascending loop in the kidney which leads to a retention of water in the urine.  No transport systems in descending loop of henle.  Inhibits Na-K-2Cl transporter in thick ascending loopof henle.  Competes with Cl- binding site.  Use : a. edema: cardiacpulmonaryor renal, b. hypertension  Example of loop diuretics include Furosemide, Bumetanide, Ethacrynicacid and Torsemide  Use : a. edema: cardiacpulmonaryor renal, b. hypertension  Example of loop diuretics include Furosemide, Bumetanide, Ethacrynicacid and Torsemide
  • 10. 9 A .Furosemide- • The major site of action is the thick AscLH where furosemide inhibits Na+-K+-2Cl-cotransport. A minor componentofaction on PT has also been indicated. It is secreted in PT by organic action transport and reaches Asc LH where it acts from luminal side of the membrane. . K+ excretion is increased mainly due to high Na+ load reaching DT. • Furosemide has weak Case inhibitory action, • increase HCO3 excretion. B. Bumetanide- • Bumetanide is similar to furosemide in all respect, but is 40 times more potent. A secondary action in PT has alsobeen demonstrated. • It is often used in people in whom high dosage of furosemide are ineffective. • It is more lipid –soluble ,oral bioavailabilityis 80%-100%.itis preferred for oral use in severe CHF. C. Ethacrynicacid- • It is a loop diuretics used totreathigh blood pressure and swelling caused by diseases like CHF.
  • 11. 10 D. Torsemide- • Another loop diureticwith properties similar to furosemide but 3 times more potent.
  • 12. 11 Thiazides :- Thiazide is a type of molecule and a class of diuretics often used to treat hypertension (high blood pressure) and edema (such as that caused by heart, liver, or kidney disease). The thiazides and thiazide-like diuretics reduce the risk of death, stroke, heart attack, and heart failure due to hypertension Mechanism of action : active in distal convoluted tubule inhibit Na+ and Cl- transporter in distal convoluted tubules increased Na+ and Cl- excretion weak inhibitors of carbonic anhydrase, increased HCO3- excretion Use : a. hypertension. b. congestive heart failure. c. high blood pressure. Example of thiazides include Chlorthalidone, Hydroclorothiazide, Metolazone
  • 13. 12 1. Hydrochlorothiazide - Hydrochlorothiazide belongs to thiazide class of diuretics. It reduces blood volume by acting on the kidneys to reduce sodium (Na+) reabsorption in the distal convoluted tubule. 2. Chlorothalidone - It is a particularly long bacting compound .use exclusively asm antihypertensive. 3. Metolazone - Inhibit PO4 reabsorption is occur in PT. Metolazone has been used mainly for edema (5-10 mg/day, rarely 20 mg). DRUG DAILY DOSE (mg) DURATION OF ACTION (hr) Hydroclorothiazide 12.5-100 6-12 Chlorothalidone 50-100 48 Metolazone 5- 20 12-24
  • 14. 13 4.Carbonic anhydrase inhibitor :- High concentration of CA occur in ciliary process of eye. CA enzyme involve in aqueous humor formation.CA inhibitors reduce intraocular pressure in glaucoma by decreasing production of aqueous humor.  Mechanismof action :  Reversibly inhibits carbonic anhydrase in renal proximal tubule cells.  carbonic anhydrase catalyzes formation of HCO3- and H+ from H2O and CO2.  Suppress CO2 reabsorption from glomerular filtrate.  Na+ - HCO3 - excretion is increased. Use : a. used to treat chronic open-angle glaucoma b. aqueous humor has high [HCO3-] c. acute mountain sickness.  Example of carbonic anhydrase inhibitor include Acetazolamide.
  • 15. 14 1. Acetazolamide – • Acetazolamide (a seet" a zol' a mide) is inhibitorSE4 of carbonic anhydrase, an enzyme that converts carbon dioxide and water to carbonic acid. Inhibition of this enzyme in the kidney causes an alkalization of the urine and diuresis. In the eye, inhibition of carbonic anhydrase causes a decrease in intraocular pressure making these agents valuable in the treatmentof glaucoma. • Acetazolamide is available in 125 and 250 mg tablets in generic forms and under the brand name of Diamox.
  • 16. 15 Potassium sparing diuretics :- Aldosterone antagonists and renal epithelial Na+ channel inhibitors indirectly conserve k+ while inducing mild natriuresis, and are called potassium sparing diuretics. Mechanismof action : K+ sparing diuretics function in CCD Do not promote the secretion of potassium into the urine. decrease Na+ transport in collecting tubule.  Aldosterone antagonist- These medicines block the action of a hormone called aldosterone and this causes the kidney to pass out more fluid and keep potassium. This is why they are sometimes referred to as aldosterone antagonists. Example of this antagonist include Spironolactone.  Inhibitor of renal epithelial Na+ channel- Triamterene and amiloride are two nonsteroidal organic base with identical action. their most important effect is to decrease K+ excretion, particularly when it is high due to large K+ intake or use of a diuretic that enhances K+ loss. This is accompanied by a small increase of Na+ excretion.
  • 17. 16 Use : a. primary hyperaldosteronism b. cirrhosis Example of potassium sparing diuretics include Spironolactone , Triamterene, Amiloride.
  • 18. 17 . Osmotic diuretics :- Osmotic diuresis is the increase of urination rate caused by the presence of certain substances in the small tubes of the kidneys.[2] The excretion occurs when substances such as glucose enter the kidney tubules and cannot be reabsorbed (due to a pathological state or the normal nature of the substance). The substances cause an increase in theosmotic pressure within the tubule, causing retention of water within the lumen, and thus reduces the reabsorption of water, increasing urine output (i.e. diuresis). Mechanismof action :  osmotic diuretics are not reabsorbed.  increases osmotic pressure specifically in the proximal tubule and loop of Henle.  prevents passive reabsorption of H2O.  increased Na+ excretion. Use : a. drug of choice: non-toxic, freely filtered, non-absorbable b. administered prophylactically for CVS disease, surgery. c. for acute renal failure secondary to trauma.
  • 19. 18 Example of osmotic diuretics include Manitol, Urea, Glycerol Manitol – Manitol is a nonelectrolyte of low molecular weight (182) that is pharmacologically inert ,can be rise osmolarity of plasma and tubular fluid. It is minimally metabolized in the body ,freely filtered at the glomerulus and undergoes limited reabsorbtion.
  • 20. 19 REFERENCE:- A. KD TRIPATHI MD (Ex-Director-Professor and Head of Pharmacology Maulana Azad Medical College and associated LN and GB Pant Hospitals New Delhi), Essentials of Medical Pharmacology, 5th Edition, 2003: 521-537. B. http://en.wikipedia.org/wiki/Diuretic. C.http://www.medpagetoday.com/MeetingCoverage/ HFC/ 32821